Overview A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor Status: Recruiting Trial end date: 2021-09-01 Target enrollment: Participant gender: Summary The objective of this study is to evaluate efficacy and safety of TQ-B3101 in subjects with advanced malignant tumor. Phase: Phase 2 Details Lead Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.